Status:
UNKNOWN
Pre-Eclampsia Prediction By Doppler Screening Of Uterine Arteries And Angiogenic Factors In Second Trimester Of Pregnancy
Lead Sponsor:
Shaare Zedek Medical Center
Conditions:
Pregnancy
Pre Eclampsia
Eligibility:
FEMALE
18-50 years
Brief Summary
BACKGROUND: Pre-eclampsia complicates about 2% of pregnancies. It accounts for at least 50 000 maternal deaths per year worldwide and is the second most common cause of maternal death in the developin...
Eligibility Criteria
Inclusion
- pregnant women in second trimester that took the routine triple test, and are having an early routine detailed ultrasound examination, in Jerusalem, Israel
Exclusion
- none
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT00725660
Start Date
September 1 2008
Last Update
July 30 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaare Zedek Medical Center
Jerusalem, Israel